Tumor Size Predicts Muscle-invasive and Non–organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg et al. · The Lancet · 2016 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +11

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Morgan Rouprêt, Marko Babjuk, Éva Compérat et al. · European Urology · 2015 · 1.3K citations

Medicine, Oncology, Urology +14

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

Arjun Vasant Balar, Daniel Castellano, Peter H. O’Donnell et al. · The Lancet Oncology · 2017 · 1.3K citations

Medicine, Oncology, Pharmacology +12

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

Vitaly Margulis, Shahrokh F. Shariat, Surena F. Matin et al. · Cancer · 2009 · 1.1K citations · Full text

Medicine, Surgery, Urology +13

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Morgan Rouprêt, Marko Babjuk, Maximilian Burger et al. · European Urology · 2020 · 941 citations · Full text

Medicine, Oncology, Urology +16